HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albumin administration combined with phototherapy in treatment of hyperbilirubinaemia in low-birth-weight infants.

Abstract
Fifty-nine jaundiced light treated newborn infants with low birth weight were studied. At onset of phototherapy 30 infants received 1 g human serum albumin per kg body weight as a 9% solution containing sodium caprylate and N-acetyltryptophan as stabilizers. 29 infants did not receive human serum albumin and served as controls. Blood samples were taken before initiation of the therapy and again 24 and 48 h thereafter, and the following determinations were made: Serum concentrations of unconjugated bilirubin, albumin, reserve albumin for binding of bilirubin by the [14C]-MADDS method, packed cell volume and pH. Before infusion of albumin it was found that the binding fraction of serum albumin, i.e. the sum of the serum concentrations of bilirubin-albumin and reserve albumin, constituted about half of the total serum albumin concentration. The other half was non-binding, in agreement with previous findings in neonates. The effect of albumin therapy was mainly an unexpected increase of the non-binding fraction of serum albumin, while the increase of the serum reserve albumin concentration was small and the concentration of bilirubin-albumin was not changed.
AuthorsF Ebbesen, R Brodersen
JournalActa paediatrica Scandinavica (Acta Paediatr Scand) Vol. 70 Issue 5 Pg. 649-53 (Sep 1981) ISSN: 0001-656X [Print] Sweden
PMID7324912 (Publication Type: Journal Article)
Chemical References
  • Serum Albumin
  • Bilirubin
Topics
  • Bilirubin (metabolism)
  • Humans
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Jaundice, Neonatal (therapy)
  • Phototherapy
  • Protein Binding
  • Serum Albumin (administration & dosage, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: